2023 Approvals
What is LAMZEDE prescribed for? For the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients. What is the name of the drug and what does it do? LAMZEDE (generic name: velmanase alfa-tycv), pronouonced “lam-zed,” is a medicine made from human genes that helps treat the
2023 Approvals
What is Augtyro prescribed for? Augtyro is prescribed for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer. What is Augtyro and what does it do? Augtyro, pronounced Aug-TYE-ro, (generic name: repotrectinib) is a newly FDA-approved medication for treating a specific type of lung
FDA
For Immediate Release: March 28, 2025Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: * On Thursday, the FDA’s Learning and Education to ADvance and Empower Rare Disease Drug Developers initiative published two new videos titled “Understanding the Importance of
Videos
Living with rheumatoid arthritis can be challenging, especially with the high cost of biologic treatments. New research from the University of Manchester shows that biosimilars—lower-cost alternatives to biologic drugs—are just as safe and effective for managing RA. This breakthrough could make life
Health and Medical Research News
What did the research discover? This study explored whether high blood pressure (hypertension) and taking blood pressure medication in later life (ages 60 and older) affect the risk of developing dementia. Researchers analyzed data from 17 studies across 15 countries, including 34,519 older adults who did not have dementia
2023 Approvals
What is Izervay prescribed for? Izervay is prescribed to treat geographic atrophy (GA) secondary to age-related macular degeneration. What is the name of the drug and what does it do? Izervay, pronounced EYE-ZER-VEY, (generic name: avacincaptad pegol) is a prescription medication approved for the treatment of geographic atrophy (GA), which
Health and Medical Research News
What did the research discover? Recent data from the U.S. Centers for Disease Control and Prevention (CDC) shows a significant rise in whooping cough (also known as pertussis) cases. For the week ending September 14, 2024 there were 291 new cases were reported, with New York and Oklahoma experiencing
Health and Medical Research News
What did the research discover? The U.S. Food and Drug Administration (FDA) has approved FluMist for self- or caregiver-administration. FluMist is a nasal spray vaccine that helps prevent the flu (influenza) in people aged 2 through 49. While FluMist has been around since 2003, it previously had to be
Diabetes
What Did the Research Discover? A systematic review and meta-analysis examined how well semaglutide helps people lose weight if they are obese or overweight but do not have diabetes. Researchers analyzed data from eight clinical trials with 4,567 participants, comparing semaglutide to a placebo. The results showed that semaglutide
Diabetes
What Did the Research Discover? Scientists developed a new type of glucose sensor called a BioTFT (Biosensing Thin-Film Transistor) that can detect glucose in saliva instead of blood. This technology is non-invasive, meaning it does not require a blood sample, and it provides results in less than 60 seconds. The
FDA
</aside> <div class="col-md-8" role="main" readability="63.196747392611"> <div class="inset-column"> <dl class="lcds-description-list--grid"> <dt class="cell-1_1">For Immediate Release:</dt> <dd class=
Health and Medical Research News
What did the research discover? This study examined whether low vitamin D levels before chemotherapy increase the risk of developing chemotherapy-induced peripheral neuropathy (CIPN) in patients receiving paclitaxel for early-stage breast cancer. CIPN is a common and painful side effect of chemotherapy that affects nerves, leading to tingling, numbness, and